BD, a leading global medical technology company, and Frazier Healthcare Partners, a leading private equity firm focused exclusively on the healthcare sector, announced a definitive agreement for BD to ...

BD's outgoing diagnostic solutions and biosciences catalog brought in about $3.4 billion in 2024 sales. It will include tests for infectious disease and cervical cancer screening, as well as flow ...

Waters and BD shareholders are set to split ownership of the new outfit at about 60-40, respectively, while BD will also receive about $4 billion in cash. (Getty Images) BD has found a new home for ...

BD (Becton, Dickinson and Company) has agreed to combine its biosciences and diagnostic solutions business with Waters Corporation, creating a new life science and diagnostics company. The agreement ...

Global medtech giant BD announced that it is adding capacity to its US-based footprint for the production of critical medical devices, including syringes, needles, and IV catheters. As part of the ...

The settlement is confidential but, in its most recent quarterly report, BD disclosed accruals for the hernia product liability claims, plus related legal defense costs, of about $1.7 billion on June ...